Holen Sie sich die Stockscreener-App
0.00
100.00%
-10.07
Schlusskurs vom Vortag:
$10.07
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$128.90M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$10.07
52-Wochen-Spanne:
$0.00
$10.10
Cantor Equity Partners Inc Stock (CEP) Company Profile
Firmenname
Cantor Equity Partners Inc
Sektor
Branche
Telefon
-
Adresse
-
Cantor Equity Partners Inc Aktie (CEP) Neueste Nachrichten
Cantor Fitzgerald Affiliated SPAC Files for $200M IPO - MarketWatch
Taxation With Representation: Kirkland, Davis Polk, Wachtell - Law360
FY2024 EPS Estimates for Pfizer Lifted by Cantor Fitzgerald - MarketBeat
Deltec Asset Management LLC Invests $502,000 in Cantor Equity Partners, Inc. Class A Ordinary Shares (NASDAQ:CEP) - MarketBeat
Cantor Fitzgerald Investment Advisors L.P. Invests $5.99 Million in Dollar General Co. (NYSE:DG) - MarketBeat
Cantor Fitzgerald Investment Advisors L.P. Has $3.26 Million Stock Position in M&T Bank Co. (NYSE:MTB) - MarketBeat
Analysts Offer Predictions for KROS FY2024 Earnings - Defense World
SHOREHAVEN MIXED-USE DEVELOPMENT TOPS OUT IN TEMPE - PR Newswire
Cantor Fitzgerald Weighs in on KROS FY2024 Earnings - Defense World
Cantor Fitzgerald Reaffirms Neutral Rating for Tesla (NASDAQ:TSLA) - Defense World
Western Digital (NASDAQ:WDC) PT Raised to $95.00 at Cantor Fitzgerald - Defense World
Keros Therapeutics (NASDAQ:KROS) Now Covered by Cantor Fitzgerald - Defense World
Cantor Fitzgerald Lowers Alkermes (NASDAQ:ALKS) Price Target to $43.00 - MarketBeat
Pfizer (NYSE:PFE) Earns Overweight Rating from Cantor Fitzgerald - MarketBeat
Cantor Fitzgerald Initiates Coverage of LeMaitre Vascular (LMAT) with Neutral Recommendation - MSN
Micron Technology (MU-Q) QuotePress Release - The Globe and Mail
UnitedHealth price target raised to $644 from $591 at Cantor Fitzgerald - Yahoo Finance
Cantor Fitzgerald Comments on Organogenesis Holdings Inc.'s FY2024 Earnings (NASDAQ:ORGO) - MarketBeat
Cantor Fitzgerald Upgrades Teradyne, Inc. (TER) to Overweight as CEO Highlights Surge in Demand for Automated Test Equipment Driven by Cloud AI Products - Yahoo Finance
Brokers Issue Forecasts for Meta Platforms, Inc.’s FY2024 Earnings (NASDAQ:META) - Defense World
Novo Nordisk A/S (NYSE:NVO) Given "Overweight" Rating at Cantor Fitzgerald - MarketBeat
Cantor Fitzgerald Reaffirms "Overweight" Rating for Alkermes (NASDAQ:ALKS) - MarketBeat
Lucid Group (NASDAQ:LCID) Earns Neutral Rating from Cantor Fitzgerald - Defense World
Zillow Group (NASDAQ:ZG) Earns Neutral Rating from Cantor Fitzgerald - MarketBeat
Cantor Fitzgerald Reiterates Neutral Rating for Spotify Technology (NYSE:SPOT) - MarketBeat
GoDaddy (NYSE:GDDY) Stock Rating Reaffirmed by Cantor Fitzgerald - MarketBeat
FY2024 Earnings Forecast for nLIGHT, Inc. Issued By Cantor Fitzgerald (NASDAQ:LASR) - Defense World
Cantor Fitzgerald Reiterates Overweight Rating for Surgery Partners (NASDAQ:SGRY) - MarketBeat
R1 RCM (NASDAQ:RCM) Stock Rating Reaffirmed by Cantor Fitzgerald - Defense World
Cantor Fitzgerald Upgrades Teradyne, Inc. (TER) to Overweight, Citing Strong AI Leverage and Industry Recovery Potential - Yahoo Finance
Vera Therapeutics (NASDAQ:VERA) Receives “Overweight” Rating from Cantor Fitzgerald - Defense World
Cantor Fitzgerald Reiterates “Neutral” Rating for Humana (NYSE:HUM) - Defense World
ICR, the Leading SPAC Communications and Advisory Firm, Publishes its SPAC Market Update & Outlook - Business Wire
Pinterest (NYSE:PINS) Rating Reiterated by Cantor Fitzgerald - MarketBeat
eBay (NASDAQ:EBAY) Stock Rating Reaffirmed by Cantor Fitzgerald - MarketBeat
Amgen initiated with an Overweight at Cantor Fitzgerald - Yahoo Finance
Amgen (NASDAQ:AMGN) Now Covered by Analysts at Cantor Fitzgerald - MarketBeat
Gilead Sciences, Inc. (NASDAQ:GILD) to Post FY2024 Earnings of $3.89 Per Share, Cantor Fitzgerald Forecasts - MarketBeat
Smartsheet to Be Bought in $8.4 Billion Deal. The Stock Is Rising. - MSN
MercadoLibre (NASDAQ:MELI) Rating Reiterated by Cantor Fitzgerald - Defense World
Innoviz Technologies (NASDAQ:INVZ) Earns “Overweight” Rating from Cantor Fitzgerald - Defense World
Cantor Fitzgerald Reaffirms Overweight Rating for Meta Platforms (NASDAQ:META) - MarketBeat
eBay's (EBAY) "Neutral" Rating Reiterated at Cantor Fitzgerald - MarketBeat
Shopify’s (SHOP) Neutral Rating Reiterated at Cantor Fitzgerald - Defense World
Codexis (NASDAQ:CDXS) Stock Rating Reaffirmed by Cantor Fitzgerald - Defense World
Humana (NYSE:HUM) Receives Neutral Rating from Cantor Fitzgerald - Defense World
Cantor Fitzgerald Reiterates “Overweight” Rating for Rivian Automotive (NASDAQ:RIVN) - Defense World
Aurinia Pharmaceuticals (NASDAQ:AUPH) Rating Reiterated by Cantor Fitzgerald - Defense World
Eli Lilly and Company (NYSE:LLY) Given Overweight Rating at Cantor Fitzgerald - Defense World
UnitedHealth Group (NYSE:UNH) Given “Overweight” Rating at Cantor Fitzgerald - Defense World
Vera Therapeutics (NASDAQ:VERA) Given “Overweight” Rating at Cantor Fitzgerald - Defense World
Finanzdaten der Cantor Equity Partners Inc-Aktie (CEP)
Es liegen keine Finanzdaten für Cantor Equity Partners Inc (CEP) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.10%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):